FDA Inspection 1292260 — Aspire Fertility Institute San Antonio
The FDA completed an inspection of Aspire Fertility Institute San Antonio on September 24, 2025 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Antonio, TX (United States)